VERMOR 10mg Price

Overview

Welcome to Dwaey, specifically on VERMOR 10mg Solution for Injection page.
This medicine contains an important and useful components, as it consists of Morphine sulphate .
VERMOR 10mg is available in the market in concentration 10 mg/ml and in the form of Solution for Injection.

VERVE HUMAN CARE LABORATORIES is the producer of VERMOR 10mg and it is imported from INDIA, The most popular alternatives of VERMOR 10mg are listed downward .

Mode Of Action

Morphine is a phenanthrene derivative which acts mainly on the CNS and smooth muscles. It binds to opiate receptors in the CNS altering pain perception and response. Analgesia, euphoria and dependence are thought to be due to its action at the mu-1 receptors while resp depression and inhibition of intestinal movements are due to action at the mu-2 receptors. Spinal analgesia is mediated by morphine agonist action at the K receptor.

Indication

• Pain
• MI
• Unstable angina
• Intractable cough
• Acute pulmonary oedema
• Analgesia during labour

Precaution

Patient w/ impaired resp function, severe bronchial asthma, convulsive disorders, acute alcoholism, delirium tremens, raised intracranial pressure, hypotension w/ hypovolaemia, cardiac arrhythmias, severe cor pulmonale, history of substance abuse, diseases of the biliary tract, pancreatitis, inflammatory bowel disorders, prostatic hypertrophy, adrenocortical insufficiency, toxic psychoses. Opioid dependent patients. Renal and hepatic impairment. Pregnancy and lactation. Patient Counselling May impair ability to drive or operate machinery. Monitoring Parameters Monitor efficacy of pain control, vital signs, and mental status; signs of drug abuse, addiction, or diversion; signs or symptoms of hypogonadism or hypoadrenalism.

Side Effects

• >10% Pruritus (?80%)
• Urinary retention (epidural/IT) (15-70%)
• Vomiting (7-70%)
• Constipation (>10%)
• Headache (>10%)
• Somnolence (>10%) 1-10% Abdominal pain (5-10%)
• Asthenia (5-10%)
• Backache (5-10%)
• Depression (5-10%)
• Diarrhea (5-10%)
• Dyspnea (5-10%)
• Fever (5-10%)
• Insomnia (5 -10% )
• Loss of appetite (5-10%)
• Nausea (5-10%)
• Paresthesia (5-10%)
• Peripheral edema (5-10%)
• Rash (5-10%)
• Sweating (5-10%)
• Xerostomia (5-10%)
• Respiratory depression (IT) (4-7%)
• Anxiety (6%)
• Dizziness (6%)
• Abnormal liver function test results (<5%)
• Amblyopia (<5%)
• Hiccups (<5%)
• Orthostatic hypotension (<5%)
• Syncope (<5%)
• Urinary retention (PO) (<5%) <1% Respiratory depression (epidural) (0.25-0.4% ) Frequency Not Defined Anaphylaxis (rare )
• Cardiac arrest
• Circulatory depression
• Finding of intracranial pressure
• Ileus
• Lightheadedness
• Malaise
• Miosis
• Myoclonus
• Shock
• Thinking disturbances
• Vertigo Potentially Fatal: Respiratory depression; circulatory failure; hypotension; deepening coma; anaphylactic reactions.

Contra indication

Respiratory depression, acute or severe asthma; paralytic ileus; obstructive airway disease; acute liver disease; comatose patients; increased intracranial pressure; acute alcoholism. Pulmonary oedema resulting from a chemical respiratory irritant.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Pregnancy category: C; D if prolonged use/high doses at term.